DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Wnt signaling pathway	R-HSA-195721	map04310	3-aminobenzamide	6505803	drug-path
Olfactory transduction	R-HSA-9751605	map04740	3-aminobenzamide	6505803	drug-path
p53 signaling pathway	R-HSA-168638	map04115	3-aminobenzamide	6505803	drug-path
Adherens junction	R-HSA-451386	map04520	bucladesine	9687	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	bucladesine	9687	drug-path
Colorectal cancer	R-HSA-4791275	map05210	bucladesine	9687	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	bucladesine	9687	drug-path
Glioma	Q9NZM4	map05214	bucladesine	9687	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	bucladesine	9687	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	bucladesine	9687	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	bucladesine	9687	drug-path
Huntington's disease	R-HSA-1643685	0	bucladesine	9687	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	bucladesine	9687	drug-path
Allograft rejection	R-HSA-9679028	map05330	bucladesine	9687	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	bucladesine	9687	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	bendroflumethiazide	4534	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	bendroflumethiazide	4534	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	bendroflumethiazide	4534	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	bendroflumethiazide	4534	drug-path
Axon guidance	R-HSA-422475	map04360	bendroflumethiazide	4534	drug-path